Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 18/20 | 0.77 |
| ▸ | CCR1 | P32246 | 1/20 | 0.77 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.77 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.77 |
| ▸ | KCNH2 | Q12809 | 8/20 | 0.68 |
| ▸ | CCR5 | P51681 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13253574 | 1.00 | CCR2 (0.77) | CCR2CCR1TMEM97SIGMAR1KCNH2 | |
| SCHEMBL13226327 | 1.00 | CCR2 (0.77) | CCR2CCR1TMEM97SIGMAR1KCNH2 | |
| SCHEMBL13226452 | 0.94 | CCR2 (0.71) | CCR2CCR1TMEM97SIGMAR1KCNH2 | |
| SCHEMBL13226455 | 0.92 | CCR2 (0.71) | CCR2CCR1TMEM97SIGMAR1KCNH2 | |
| SCHEMBL13226462 | 0.91 | CCR2 (0.66) | CCR2CCR1TMEM97SIGMAR1KCNH2 | |
| SCHEMBL13226517 | 0.91 | CCR2 (0.68) | CCR2CCR1TMEM97SIGMAR1KCNH2 | |
| SCHEMBL13226457 | 0.91 | CCR2 (0.68) | CCR2CCR1TMEM97SIGMAR1KCNH2 | |
| SCHEMBL13226445 | 0.91 | CCR2 (0.69) | CCR2CCR1TMEM97SIGMAR1KCNH2 | |
| SCHEMBL13226466 | 0.90 | CCR2 (0.66) | CCR2CCR1TMEM97SIGMAR1KCNH2 | |
| SCHEMBL13226395 | 0.90 | CCR2 (0.84) | CCR2CCR1TMEM97SIGMAR1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200405889-A1 | METHODS FOR DETECTING CCR2 RECEPTORS | WASHINGTON UNIVERSITY (US) | 2020-12-31 | — | — | US | disclosed |
| US-20170348442-A1 | COMPOSITIONS AND METHODS FOR DETECTING CCR2 RECEPTORS | WASHINGTON UNIVERSITY (US) | 2017-12-07 | — | — | US | disclosed |
| US-20170348442-A1 | COMPOSITIONS AND METHODS FOR DETECTING CCR2 RECEPTORS | WASHINGTON UNIVERSITY (US) | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170348442-A1 | COMPOSITIONS AND METHODS FOR DETECTING CCR2 RECEPTORS | CCR2, CCR1, CCR3 | CCR2 1/4885CCR1 2/4885TMEM97 449/4885 |
| US-20200405889-A1 | METHODS FOR DETECTING CCR2 RECEPTORS | CCR2, CCR1, CCR5 | CCR2 1/4885CCR1 2/4885TMEM97 422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.